Ethical Analysis of Merck and Vioxx How could Merck management have handled the research, development and marketing of Vioxx in a more ethically responsible fashion, if at all? On September 30, 2004, Merck & Company declared the drawback associated with Vioxx, its extremely profitable pain reducer for osteoarthritis victims, from the marketplace. This particular move came only 7 days after scientists within the company discovered in a medical trial that subjects who

Scientists should not perform testing of drugs, chemicals and cosmetics on animals. No matter how many animals they use, they cannot prove the new substances are perfectly safe and effective. If the substances pass animal testing and don't show any ill effects on animals, it doesn't mean the substances are a hundred percent safe for humans. Terrifyingly, the substances can cause serious side effects in humans. Because the physical structures

Vioxx demonstrates the unethical practice perpetuated within the business community. Typically, the pharmaceutical companies often put their financial interests above the health and safety of drug users. The paper also highlighted the unethical drug approval process implemented by FDA. The paper suggests that the government should introduce tougher drug approval process to ensure that FDA approves only the ethical products into the market. The case provides the overview of a

More than anything else, this case exemplifies a keen sense of legal risk management. The company made enormous profits from the drug while it was selling it; it was highly effective for its on-label purpose and had no known dangerous side effects. After finding that they could be responsible for causing heart problems in patients taking the drug, the company pulled it for ethical reasons and as a means of

(Chizek, 2003) The Role legal nurse consultant may provide service in a number of roles, including but not limited to: Consulting expert Testifying expert Facility-based investigator Trainer and in-service presenter Peer reviewer Quality improvement, risk management, claims management Liability insurance marketer and clinical resource" (Chizek, 2003) As standards of care constantly change, medical and nursing staff must keep informed of current standard to develop and/or modify policies and procedures, which must be maintained and secured indefinitely. In the

Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit